ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
FDA Grants Orphan Drug Designation for Progressive SupraNuclear Palsy Treatment
March 09, 2020Retrotope announced the U.S. Food and Drug Administration (FDA) Office of Orphan Products Development granted orphan drug designation for its chemically-modified polyunsaturated fatty acid drug (RT001) ... -
Retrotope Announces First Dosing of RT001 in Friedreich’s Ataxia Study
January 15, 2020Retrotope has dosed its first patient in a Phase 2/3 clinical trial of RT001 in Friedreich’s ataxia, the most common of the inherited ataxias. RT001, a stabilized fatty acid drug, has been shown to reduce lipid peroxidation leading to cell death in ...
Pharma Sources Insight January 2025
